Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : mRNA-based Therapy
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : Nanovation Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
ME Therapeutics Begins Testing mRNA Formulations with NanoVation Therapeutics
Details : The collaboration aims to enhance the precision and efficacy of mRNA therapeutics to develop potential new cancer therapies by leveraging the cutting-edge LNP technologies of NanoVation.
Brand Name : Undisclosed
Molecule Type : Large molecule
Upfront Cash : Undisclosed
September 20, 2024
Lead Product(s) : mRNA-based Therapy
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : Nanovation Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?